Skip to main content
. 2019 Jul 3;33(4):1355–1362. doi: 10.21873/invivo.11611

Table I. Characteristics of patients with haematological malignancies who received HEC or MEC.

graphic file with name in_vivo-33-1357-i0001.jpg

Except for age, data are presented as numbers of patients. ECOG, Eastern Cooperative Oncology Group; HEC, highly emetogenic chemotherapy; MEC, moderately emetogenic chemotherapy; NA, not applicable.